Currencies / LLY
LLY: Eli Lilly and Company
757.79
USD
19.44
(2.63%)
LLY exchange rate has changed by 2.63% for today. During the day, the instrument was traded at a low of 738.08 and at a high of 758.86.
Follow Eli Lilly and Company dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
LLY News
- Reuters Novo Nordisk should look to the US for its next CEO, analysts say
- Investing Analysis-Novo Nordisk should look to the US for its next CEO, analysts say
- Reuters From insulin to Ozempic, history of Novo Nordisk's CEOs
- Investing From insulin to Ozempic, history of Novo Nordisk’s CEOs
- Investing UnitedHealth, Eli Lilly lead Friday’s market cap stock movers
- Investor's Business Daily Hims Stock Rockets On Novo Nordisk Partnership After FDA Weight-Loss Drug Ruling Crashes Shares
- Investor's Business Daily Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price
- Investing Google, Eli Lilly lead Friday’s market cap stock movers
- Reuters Obesity drug maker Novo Nordisk ousts CEO as competition weighs
- MarketWatch Ozempic maker Novo Nordisk boots CEO over stock-price fall
- Investing Obesity drug maker Novo Nordisk’s CEO to step down amid market struggle
- Seeking Alpha Does Anavex's Alzheimer's Drug Actually Confer Benefit? (NASDAQ:AVXL)
- Benzinga Eli Lilly Collaborates With Rznomics On Hearing Loss Treatment In $1.3 Billion Pact - Eli Lilly (NYSE:LLY)
- Investing Eli Lilly at BofA Conference: Strategic Insights on Growth and Challenges
- Investing Canaccord maintains Buy on Verve stock, $39 price target
- Investing Citizens JMP reiterates Foghorn stock with $9 target
- Investing Truist highlights court ruling insights on FDA drug list case
- GuruFocus Eli Lilly Shares Tumble After Rival Novo Nordisk Strikes Major Weight Loss Deal
- Benzinga Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030 - Sanofi (NASDAQ:SNY)
- Investing AbbVie, Nvidia, and Exelixis Lead Market Cap Stock Movers on Wednesday
- Reuters Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments
- Investor's Business Daily Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna Skyrocketing
- Investing Roche says Trump’s drug price order threatens its $50 billion US investment plans
- Investing Bernstein reiterates Eli Lilly outperform with $1,100 target
Daily Range
738.08
758.86
Year Range
677.09
972.53
- Previous Close
- 733.71
- Open
- 738.35
- Bid
- 757.79
- Ask
- 758.09
- Low
- 738.08
- High
- 758.86
- Volume
- 6.892 K
- Daily Change
- 2.63%
- Month Change
- -10.27%
- 6 Months Change
- -5.00%
- Year Change
- -8.02%
18 May, Sunday
21:35
USD
- Act
- Fcst
- Prev